Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Learn more

  • Federal grantsHow to Find Grants for Nonprofits
  • Healthcare RFPsHealthcare and Medical Services Bids and Bidding Guide
  • How to apply for a grantGrant Applications vs. RFPs: Writing Differences Explained
More healthcare and medical services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Closed bids
  3. ›Federal
  4. ›Ancillary Studies to Ongoing Clinical Projects (R21…

U.S. National Institutes of Health·United States of America

Ancillary Studies to Ongoing Clinical Projects (R21 Clinical Trial Not Allowed)

Closes 12/5/2025$250kGrants Notice
Bid source

This opportunity has closed.

Bid Banana tracks 1.6M+ bids and awards across all 50 states. Save a search and we'll email your new matches, daily or weekly — so the next one reaches you with time to bid.

Get alerted next time

Description

The National Institutes of Health (NIH) is seeking applications for ancillary studies to ongoing clinical projects. The purpose of this funding opportunity is to support ancillary studies that can be carried out in conjunction with ongoing clinical projects. The studies should be focused on arthritis, musculoskeletal, and skin diseases research. • The application should be submitted electronically through the eRA Commons. • The award will be for a maximum of $250,000. • The project period is not explicitly mentioned, but the application is due on December 05, 2025. • Eligible applicants include county governments, city or township governments, special district governments, state governments, independent school districts, native American tribal organizations, public and state controlled institutions of higher education, private institutions of higher education, nonprofits, and for-profit organizations. • The funding instrument will be a grant.

Attached files

Contact

[email protected]

(301) 402-2541

Key dates

Opened
11/21/2022
Closes
12/5/2025

Last updated

Details

Type
Grants Notice
Industry
Healthcare and Medical Services
NAICS
541710
Solicitation №
PAR-25-230

Budget estimate

$250,000

The Award Ceiling is explicitly stated on the source site.

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one too late. Don't find the next one too late.

Bid Banana searches open government bids across all 50 states, updated daily. Save a search once and we email you your new matches, daily or weekly, while there is still time to win them.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. National Institutes of Health·United States of America

Top match · 74%

Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed)

Closes 7/20/2028Opened 6/9/2025

U.S. National Institutes of Health·United States of America

74% match

NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Not Allowed)

Closes 1/7/2028Opened 12/18/2024

U.S. National Institutes of Health·United States of America

73% match

NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)

Closes 1/7/2028Opened 5/5/2020

U.S. National Institutes of Health·United States of America

72% match

NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Required)

Closes 1/7/2028Opened 12/18/2024

U.S. National Institutes of Health·United States of America

72% match

Development of Animal Models and Related Biological Materials for Research (R21 Clinical Trial Not Allowed)

Closes 1/7/2028Opened 3/17/2021

U.S. National Institutes of Health·United States of America

71% match

NIH Research Program Projects (Parent P01 Clinical Trial Optional)

Closes 5/25/2029Opened 2/11/2026

U.S. National Institutes of Health·United States of America

71% match

Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

Closes 11/10/2026Opened 9/8/2025

U.S. National Institutes of Health·United States of America

71% match

NIAID Resource-Related Research Projects (R24 Clinical Trial Not Allowed)

Closes 5/25/2029Opened 6/12/2025

U.S. National Institutes of Health·United States of America

71% match

Exploratory Grants in Cancer Control (R21 Clinical Trial Optional)

Closes 9/7/2028Opened 11/12/2024

U.S. National Institutes of Health·United States of America

71% match

Early to Definitive Clinical Trials (R61/R33 Clinical Trial Required)

Closes 7/30/2027Opened 9/29/2026

U.S. National Institutes of Health·United States of America

71% match

Clinical Trials and Ancillary Studies Conducted within NIH-Funded Clinical Trial Research Networks (UG3/UH3 - Clinical Trial Required)

Closes 11/9/2026Opened 3/16/2026

U.S. National Institutes of Health·United States of America

70% match

Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed)

Closes 11/2/2026Opened 11/6/2023

U.S. National Institutes of Health·United States of America

70% match

NIH Research Project Grant (Parent R01 Clinical Trial Required)

Closes 1/7/2028Opened 12/18/2024

U.S. National Institutes of Health·United States of America

70% match

NIAID Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required)

Closes 7/5/2029Opened 6/27/2025

U.S. National Institutes of Health·United States of America

70% match

Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required)

Closes 11/2/2028Opened 5/9/2025

U.S. National Institutes of Health·United States of America

70% match

Accelerating the Pace of Substance Use Research Using Existing Data (R21 Clinical Trial Not Allowed)

Closes 12/3/2027Opened 12/5/2024

U.S. National Institutes of Health·United States of America

70% match

National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)

Closes 1/7/2027Opened 12/15/2023

U.S. National Institutes of Health·United States of America

70% match

Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)

Closes 11/17/2026Opened 8/1/2023

U.S. National Institutes of Health·United States of America

70% match

Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Not Allowed)

Closes 1/7/2028Opened 3/25/2021

U.S. National Institutes of Health·United States of America

70% match

NHLBI Clinical Trial Pilot Studies (R34 Clinical Trial Optional)

Closes 3/16/2027Opened 11/3/2023

U.S. National Institutes of Health·United States of America

69% match

Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed)

Closes 7/2/2027Opened 7/5/2023

U.S. National Institutes of Health·United States of America

69% match

INCLUDE Project: Clinical Trials Phased Awards for Down syndrome Research (R61/R33 Clinical Trial Required)

Closes 6/15/2028Opened 9/25/2025

U.S. National Institutes of Health·United States of America

69% match

Development of Collaborative Research Facilities or Research-Resource Facilities (C06 Clinical Trial Not Allowed)

Closes 1/25/2028Opened 6/17/2025

U.S. National Institutes of Health·United States of America

69% match

Mechanism for Time-Sensitive Substance Use Research (R21 Clinical Trial Optional)

Closes 9/9/2027Opened 9/20/2024

U.S. National Institutes of Health·United States of America

69% match

NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed)

Closes 1/7/2028Opened 5/7/2020